1. Home
  2. ENS vs SRRK Comparison

ENS vs SRRK Comparison

Compare ENS & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENS
  • SRRK
  • Stock Information
  • Founded
  • ENS 1991
  • SRRK 2012
  • Country
  • ENS United States
  • SRRK United States
  • Employees
  • ENS N/A
  • SRRK N/A
  • Industry
  • ENS Industrial Machinery/Components
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ENS Technology
  • SRRK Health Care
  • Exchange
  • ENS Nasdaq
  • SRRK Nasdaq
  • Market Cap
  • ENS 3.9B
  • SRRK 4.2B
  • IPO Year
  • ENS N/A
  • SRRK 2018
  • Fundamental
  • Price
  • ENS $92.88
  • SRRK $44.78
  • Analyst Decision
  • ENS Buy
  • SRRK Strong Buy
  • Analyst Count
  • ENS 3
  • SRRK 7
  • Target Price
  • ENS $120.00
  • SRRK $40.43
  • AVG Volume (30 Days)
  • ENS 304.4K
  • SRRK 1.3M
  • Earning Date
  • ENS 02-05-2025
  • SRRK 11-12-2024
  • Dividend Yield
  • ENS 1.01%
  • SRRK N/A
  • EPS Growth
  • ENS 20.93
  • SRRK N/A
  • EPS
  • ENS 7.05
  • SRRK N/A
  • Revenue
  • ENS $3,508,854,000.00
  • SRRK N/A
  • Revenue This Year
  • ENS $4.08
  • SRRK N/A
  • Revenue Next Year
  • ENS $2.60
  • SRRK N/A
  • P/E Ratio
  • ENS $13.11
  • SRRK N/A
  • Revenue Growth
  • ENS N/A
  • SRRK N/A
  • 52 Week Low
  • ENS $86.41
  • SRRK $6.76
  • 52 Week High
  • ENS $112.53
  • SRRK $46.19
  • Technical
  • Relative Strength Index (RSI)
  • ENS 42.00
  • SRRK 67.23
  • Support Level
  • ENS $90.82
  • SRRK $40.22
  • Resistance Level
  • ENS $100.16
  • SRRK $44.22
  • Average True Range (ATR)
  • ENS 2.12
  • SRRK 2.80
  • MACD
  • ENS -0.18
  • SRRK -0.30
  • Stochastic Oscillator
  • ENS 20.02
  • SRRK 84.04

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers worldwide. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

Share on Social Networks: